XML 71 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Description of Business, Basis of Presentation and Significant Accounting Policies (Tables)
12 Months Ended
Nov. 30, 2019
Accounting Policies [Abstract]  
Disaggregation of Revenue
The following table provides information about disaggregated revenue by products and services:
 
   Twelve months ended 
   November 30, 2019   November 30, 2018 
Processing and storage fees
  $29,991,972   $27,817,872 
Public banking revenue
   652,204    296,295 
Licensee and royalty income
   1,000,000    1,000,000 
Product revenue
   172,395    104,323 
  
 
 
   
 
 
 
  $31,816,571   $29,218,490 
  
 
 
   
 
 
 
Schedule of Assets and Liabilities From Contracts With Customers
The following table provides information about assets and liabilities from contracts with customers:
 
   November 30, 2019   At Adoption 
Contract assets (sales commissions)
  $398,535   $329,231 
Accounts receivables
  $6,097,331   $5,867,335 
Short-term contract liabilities (deferred revenue)
  $8,875,138   $8,365,284 
Long-term contract liabilities (deferred revenue)
  $23,633,373   $20,317,231 
The Company, in general, requires the customer to pay for processing and storage services at the time of processing. Contract assets include deferred contract acquisition costs, which will be amortized along with the associated revenue. Contract liabilities include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract. Accounts receivable consists of amounts due from clients that have enrolled and processed in the umbilical cord blood stem cell processing and storage programs related to renewals of annual plans and amounts due from license affiliates, and sublicensee territories. The Company did not have asset impairment charges related to contract assets in the twelve
months
ended November 30, 2019.
The following table presents changes in the Company’s contract assets and liabilities during the twelve months ended November 30, 2019:
 
   Balance at
December 1, 2018
   Additions   Deductions   Balance at
November 30,
 
2019
 
Contract assets (sales commissions)
  $329,231   $88,569   ($19,265  $398,535 
Accounts receivables
  $5,867,335   $36,579,504   ($36,349,508  $6,097,331 
Contract liabilities (deferred revenue)
  $28,682,515   $18,759,963   ($14,933,967  $32,508,511 
Estimated Useful Lives of Property and Equipment Estimated useful lives of property and equipment are as follows:
Furniture and equipment  
3-10
years
 
 
 
Leasehold improvements  Lesser of
8-10
years or the lives of the leases
 
 
 
Computer software – internal use  
1-5
years
Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table summarizes the financial assets and liabilities measured at fair value on a recurring basis as of November 30, 2019 and November 30, 2018, respectively, segregated among the appropriate levels within the fair value hierarchy:
 
   
Fair Value at
   at November 30, 2019 Using 
Description
  November 30,
2019
   Level 1   Level 2   Level 3 
Assets:
        
Marketable securities
  $904,053   $904,053         
  
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $904,053   $904,053         
  
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
        
Contingent consideration
  $3,495,057   $       $3,495,057 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $3,495,057   $       $3,495,057 
  
 
 
   
 
 
   
 
 
   
 
 
 
Contingent Consideration:
        
Beginning Balance as of November 30, 2018
  $4,282,975       
Subtractions – Cord:Use earnout payment
   (45,000      
Fair value adjustment as of November 30, 2019
   (742,918      
  
 
 
       
Ending balance as of November 30, 2019
  $3,495,057       
  
 
 
       
   
Fair Value at
   Fair Value Measurements
at November 30, 2018 Using
 
Description
  November 30,
2018
   Level 1   Level 2   Level 3 
Assets:
        
Trading securities
  $68,816   $68,816    —      —   
Available-for-sale
securities
   806,873    806,873    —      —   
  
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $875,689   $875,689    —      —   
  
 
 
   
 
 
   
 
 
   
 
 
 
Liabilities:
        
Contingent consideration
  $4,282,975   $—      —     $4,282,975 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total
  $4,282,975   $—      —     $4,282,975 
  
 
 
   
 
 
   
 
 
   
 
 
 
Calculation of Basic and Diluted Net (loss) Income per Common Share The composition of basic and diluted net (loss) income per share is as follows:
   November 30, 2019   November 30, 2018 
Numerator:
    
Net income (loss)
  $2,290,774   ($854,824
Denominator:
    
Weighted-average shares outstanding-basic
   7,794,828    7,463,051 
Dilutive common shares issuable upon exercise of stock options
   617,586    —   
  
 
 
   
 
 
 
Weighted-average shares-diluted
   8,412,414    7,463,051 
  
 
 
   
 
 
 
Income(Loss) per share:
    
Basic
  $0.29   ($0.11
  
 
 
   
 
 
 
Diluted
  $0.27   ($0.11